doi: 10.1155/2017/7265238
Tirzepatide (Mounjaro or Zepbound) Tirzepatide is a newer dual-action medication that mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) another hormone involved in appetite and glucose regulation
Precedent: CagriSema Success Supports Combination Approach The strongest evidence supporting a cagrilintide blend with retatrutide comes from Novo Nordisk's CagriSema program, which combines cagrilintide with semaglutide (a GLP-1 receptor agonist)
Mary Sco, a physician and nutrition expert, told CTV News Monday that this social media chatter is theoretical so far, since there has been no evidence presented of retatrutide having any kind of an effect on the emotions of users regarding love or relationships
(At this time, fecal transplants are only indicated for a bacterial infection called Clostridium difficile
3,5 Key Considerations When Stopping GLP-1s Nutritional Considerations One of the most important physiological effects of GLP-1 agonists is appetite suppression